Duvillard, Laurence
Inserm · Université de Bourgogne · CHU Dijon Bourgogne · Centre de recherche Translationnelle en Médecine moléculaire
3 papers on CoChatORCID 0000-0001-9320-793X
Most cited papers
- Verified
Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus
Vergès, B., Duvillard, L., Pais de Barros, J. P., Bouillet, B., Baillot-Rudoni, S., Rouland, A., Sberna, A.-L., Petit, J.-M., Degrace, P., & Demizieux, L. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology
Lipid metabolism and disordersDiabetes Treatment and Management
Cited by 75
- Verified
Liraglutide Increases the Catabolism of Apolipoprotein B100–Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression
Vergès, B., Duvillard, L., Pais de Barros, J. P., Bouillet, B., Baillot-Rudoni, S., Rouland, A., Petit, J. M., Degrace, P., & Demizieux, L. (2021) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health
Cited by 54
- Verified
Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation
Faivre, L., Saugier-Veber, P., Pais de Barros, J.-P., Verges, B., Couret, B., Lorcerie, B., Thauvin, C., Charbonnier, F., Huet, F., Gambert, P., et al. (2005) · European Journal of Human Genetics
Lipid metabolism and disordersLysosomal Storage Disorders Research
Cited by 34
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free